Skip to main content
OpenTrials
Completed

NCT Number: NCT03406416

Study of a Suprachoroidal Retinal Prosthesis

This study is a proof of principal, to evaluate a safety and efficacy of a prototype suprachoroidal retinal implant.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre for Eye Research Australia

Melbourne, Victoria, 3002, Australia

About this study

Retinal visual prostheses are currently in early development as an intervention to improve functional vision in people who have become blind from retinal degenerative eye disease. This study follows on from an initial proof of concept study (n=3) between 2012 and 2014, and will test a second-generation retinal prosthesis device, which has the ability to be used outside of the laboratory environment (i.e. is fully implantable).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years or older
  • Either gender
  • A confirmed history of outer retinal degenerative disease such as retinitis pigmentosa or choroideremia
  • Remaining visual acuity of bare light perception or less in both eyes
  • Functional inner retina (ganglion cells and optic nerve), as shown by the ability to perceive light and/or a measurable corneal electrically evoked visual response
  • A history of at least 10 years of useful form vision in the worse seeing eye

Exclusion criteria

  • Optic nerve disease (history of glaucoma of More than 1 month, or history of any other optic neuropathy)
  • Diseases of the inner retina including, but not limited to, central retinal artery or vein occlusion (CRAO, CRVO), end stage diabetic retinopathy, retinal detachment, traumatic retinal damage, infectious retinal disease, inflammatory retinal disease.
  • Inability to visualise the retina due to corneal or other ocular media opacities (corneal degenerations, dense cataracts, trauma, lid malpositions)
  • Any ocular condition that predisposes the participant to rubbing their eyes
  • Cognitive deficiencies, including dementia or progressive neurological disease
  • Psychiatric disorders, including depression, as diagnosed by a qualified psychologist
  • Deafness or significant hearing loss
  • Inability to speak or understand English
  • Pregnancy
  • Presence of a cochlear implant
  • Participant enrolled in another investigational drug or device trial for the treatment of their ocular condition
  • Poor general health, which would exclude them from obtaining a general anaesthetic
  • Unrealistic expectations of the investigational device to provide functional vision
  • Poorly controlled diabetes
  • Epilepsy
  • Unsuitable level of regular nystagmus (which would prevent ocular images from being obtained)
  • Anyone with medical devices (implanted or carried) that could cause serious health problems if compromised by electro-magnetic interference

Treatment and study plan

44Ch Bionic Eye Device

Device

Prototype wide view suprachoroidal retinal prosthesis

Primary outcomes

  1. Number and severity of device related serious adverse events (SAEs)

    Time frame: 2 years

    The safety of the surgical implantation assessed by the number and severity of serious adverse events (SAEs) compared to other retinal prosthesis.

Secondary outcomes

  1. Efficacy - visual response

    Time frame: 2 years

    The ability to generate a visual response accessed via repeatable threshold measurements of visual perception.

  2. Visual Function and Functional Vision

    Time frame: 2 years

    Visual function and Functional Vision will be scored from performance on a range of acuity, orientation and mobility, and activities of daily living tasks. Outcome measures include:

    • Grating visual acuity: record the grating acuity level and average response time.
    • Square localization: response error and response time is measured.
    • Motion detection: response error and response time is measured.
    • Table top task: locate and identify objects on a table. Accuracy rates and response times will be recorded.
    • Doorway detection task: to find doorway target. Task time and accuracy of door touch will be recorded.
    • Obstacle avoidance task: task time and number of collisions is recorded.
    • Functional Low Vision Observer Rated Assessment (FLORA): this assessment tool Is used to evaluate participant functional vision and mobility.
  3. Quality of life - IVI - very low vision validated questionnaire

    Time frame: 2 years

    Quality of life will be assessed via survey and self-report. The Functional Low Vision Observer Assessment (FLORA) is a questionnaire that will be used to measure participants changes in participant daily living experiences.

Sponsors and collaborators

Lead sponsor

Mobius Medical Pty Ltd.

Industry

Collaborators

  • Australian National University
  • Bionic Vision Technologies
  • Center for Eye Research Australia
  • Data 61 CSIRO
  • The Bionics Institute of Australia
  • University of Melbourne

Registry information

Official study title

Evaluation of a Suprachoroidal Retinal Prosthesis: A 44 Channel Fully Implantable Study

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Jan 23, 2018
Registry last updated
Aug 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.